News | November 15, 2022
IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations
Kauliv provides reusable and disposable pen2 device options to cater to the global market demand.
The European Commission will review the CHMP recommendation and is expected to make a final decision soon.
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
Subscribe To Our Newsletter & Stay Updated
